Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Journal of Hazardous Materials
|
April 16, 2025
Enhanced plasma-driven H<sub>2</sub>S removal from natural gas via TiO<sub>2</sub>-coated dielectric surface modification
Xingwang Wu, Chenyang Shen, Yingwen Li, et al.
Clinical Drug Investigation
|
March 19, 2025
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRAS<sup>G12C</sup>, in Healthy Chinese Subjects
Yue Liu, Xin Gao, Yang Li, et al.
Nature Communications
|
March 11, 2026
Textured piezoelectric ceramics with reduced grain size for high-frequency transducer applications
Yizhou Xiao, Shuai Yang, Mingwen Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 28, 2016
Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives
Xiaoping Zhan, Weixi Qin, Shuai Wang, et al.
JACS Au
|
April 3, 2023
Plasma-Catalytic CO<sub>2</sub> Reforming of Toluene over Hydrotalcite-Derived NiFe/(Mg, Al)O <sub></sub> Catalysts
Lina Liu, Jing Dai, Sonali Das, et al.
Drug Design, Development and Therapy
|
March 27, 2023
Effect of Different Doses of Butorphanol on Postoperative Shivering in Elderly Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Yaolin Wang, Kai Zhao, Nanling Wu, et al.
Carcinogenesis
|
January 10, 2006
Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors
Shu Lu, Kate Shen, Yaolin Wang, et al.
Journal of Colloid and Interface Science
|
July 4, 2026
Efficient hydrogen production and anti-coking via reforming of waste plastics by oxygen vacancy promoted plasma-catalysis
Haijun Wu, Shenggui Ma, Dianhang Wei, et al.
Cancer Biology & Therapy
|
September 1, 2005
DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression
Y Alan Wang, Yeugeniya Kamarova, Kate C Shen, et al.
The Oncologist
|
March 11, 2022
Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer
Hong Jian, Kai Wang, Ying Cheng, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Journal of Hazardous Materials
|
April 16, 2025
Enhanced plasma-driven H<sub>2</sub>S removal from natural gas via TiO<sub>2</sub>-coated dielectric surface modification
Xingwang Wu, Chenyang Shen, Yingwen Li, et al.
Clinical Drug Investigation
|
March 19, 2025
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRAS<sup>G12C</sup>, in Healthy Chinese Subjects
Yue Liu, Xin Gao, Yang Li, et al.
Nature Communications
|
March 11, 2026
Textured piezoelectric ceramics with reduced grain size for high-frequency transducer applications
Yizhou Xiao, Shuai Yang, Mingwen Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 28, 2016
Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives
Xiaoping Zhan, Weixi Qin, Shuai Wang, et al.
JACS Au
|
April 3, 2023
Plasma-Catalytic CO<sub>2</sub> Reforming of Toluene over Hydrotalcite-Derived NiFe/(Mg, Al)O <sub></sub> Catalysts
Lina Liu, Jing Dai, Sonali Das, et al.
Drug Design, Development and Therapy
|
March 27, 2023
Effect of Different Doses of Butorphanol on Postoperative Shivering in Elderly Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Yaolin Wang, Kai Zhao, Nanling Wu, et al.
Carcinogenesis
|
January 10, 2006
Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors
Shu Lu, Kate Shen, Yaolin Wang, et al.
Journal of Colloid and Interface Science
|
July 4, 2026
Efficient hydrogen production and anti-coking via reforming of waste plastics by oxygen vacancy promoted plasma-catalysis
Haijun Wu, Shenggui Ma, Dianhang Wei, et al.
Cancer Biology & Therapy
|
September 1, 2005
DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression
Y Alan Wang, Yeugeniya Kamarova, Kate C Shen, et al.
The Oncologist
|
March 11, 2022
Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer
Hong Jian, Kai Wang, Ying Cheng, et al.
Page
of 7